BZBrinley N. Zabriskie

Brinley N. Zabriskie

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Brinley N. Zabriskie has a total of 26 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • The Use of Machine Learning in Pediatric Research

    by Brinley N. Zabriskie, Austin J. Bowles

  • Open Access

    Special Issue: Association between type-2 diabetes and Toxoplasma gondii seropositivity: a systematic review and meta-analysis

    by Ashley Catchpole, Brinley N. Zabriskie, Bradley Embley, Hannah Kharazi, Rachelle Clarke, Grace Templeton, Christopher Hunt, Shawn D. Gale, Dawson W. Hedges

    A metabolic disease resulting in elevated blood glucose levels, type-2 diabetes affects approximately 462 million people globally. Although its prevalence appears to be increasing, type-2 diabetes has been associated with various potentially preventable risk factors, including infectious diseases. The protozoal infection with Toxoplasma gondii (Nicolle et Manceaux, 1908) has been associated with type-2 diabetes in two previous meta-analyses. Since the publication of the last meta-analysis supporting an association between type-2 diabetes and T. gondii, several new primary studies have investigated this association. In this meta-analysis, we sought to further characterise the association between type-2 diabetes and T. gondii. We identified primary studies using PubMed, Embase, Scopus and Web of Science. Twenty-five studies met our inclusion criteria for a total of 4,639 patients with type-2 diabetes and 3,492 controls. Eighteen primary studies found a positive association between type-2 diabetes and T. gondii, whereas seven did not. Using a frequentist random-effects meta-analysis model, we found an overall summary odds ratio of 2.77 (95-percent confidence interval: 2.03-3.76), suggesting that the odds people will have type-2 diabetes is 2.7 times higher for people seropositive for T. gondii. Future studies should investigate this association in additional geographical regions and explore whether this association is due to the immunosuppressive effects of type-2 diabetes or whether T. gondii directly or indirectly affects glucose metabolism, or both.


  • Open Access

    Human Papillomavirus Positivity and Cognitive Function in Older U.S. Adults: A Cross-Sectional Population-Based Study

    by Thomas J. Farrer, Jonathan D. Moore, Brinley N. Zabriskie, Morgan Chase, Chris H. Miller, Shawn D. Gale, Dawson W. Hedges

    Prior research has reported an association between human papillomavirus (HPV) seropositivity and dementia or Alzheimer’s disease. This study aimed to cross-sectionally investigate the association between HPV seropositivity and cognitive function in older adults. The data used for this study were from the 2011–2014 National Health and Nutrition Examination Survey (NHANES) cycles. To account for the complex survey design and missing data, we applied survey-weighted regression models to each imputed dataset, using multiple imputation techniques. Across all cognitive test outcomes, no statistically significant association was observed between HPV status and cognitive performance after controlling for covariates. These findings suggest that there may not be a significant association between HPV infection and cognitive scores in this NHANES sample. Stakeholders, including policymakers and healthcare providers, should consider these findings in their professional decision-making. Future research should investigate the association between HPV seropositivity and cognition using other samples in order to further characterize the association between HPV and cognitive function in older adults.


  • The impact of correction methods on rare‐event meta‐analysis

    by Brinley N. Zabriskie, Nolan Cole, Jacob Baldauf, Craig Decker

    Meta‐analyses have become the gold standard for synthesizing evidence from multiple clinical trials, and they are especially useful when outcomes are rare or adverse since individual trials often lack sufficient power to detect a treatment effect. However, when zero events are observed in one or both treatment arms in a trial, commonly used meta‐analysis methods can perform poorly. Continuity corrections (CCs), and numerical adjustments to the data to make computations feasible, have been proposed to ameliorate this issue. While the impact of various CCs on meta‐analyses with rare events has been explored, how this impact varies based on the choice of pooling method and heterogeneity variance estimator is not widely understood. We compare several correction methods via a simulation study with a variety of commonly used meta‐analysis methods. We consider how these method combinations impact important meta‐analysis results, such as the estimated overall treatment effect, 95% confidence interval coverage, and Type I error rate. We also provide a website application of these results to aid researchers in selecting meta‐analysis methods for rare‐event data sets. Overall, no one‐method combination can be consistently recommended, but some general trends are evident. For example, when there is no heterogeneity variance, we find that all pooling methods can perform well when paired with a specific correction method. Additionally, removing studies with zero events can work very well when there is no heterogeneity variance, while excluding single‐zero studies results in poorer method performance when there is non‐negligible heterogeneity variance and is not recommended.


  • Open Access

    Association between Toxoplasma gondii Infection and Type-1 Diabetes Mellitus: A Systematic Review and Meta-Analysis

    by Ashley Catchpole, Brinley N. Zabriskie, Pierce Bassett, Bradley Embley, David White, Shawn D. Gale, Dawson Hedges

    Type-1 diabetes, an autoimmune disease characterized by damage to pancreatic insulin-producing beta cells, is associated with adverse renal, retinal, cardiovascular, and cognitive outcomes, possibly including dementia. Moreover, the protozoal parasite Toxoplasma gondii has been associated with type-1 diabetes. To better characterize the association between type-1 diabetes and Toxoplasma gondii infection, we conducted a systematic review and meta-analysis of published studies that evaluated the relationship between type-1 diabetes and Toxoplasma gondii infection. A random-effects model based on nine primary studies (total number of participants = 2655) that met our inclusion criteria demonstrated a pooled odds ratio of 2.45 (95% confidence interval, 0.91–6.61). Removing one outlying study increased the pooled odds ratio to 3.38 (95% confidence interval, 2.09–5.48). These findings suggest that Toxoplasma gondii infection might be positively associated with type-1 diabetes, although more research is needed to better characterize this association. Additional research is required to determine whether changes in immune function due to type-1 diabetes increase the risk of infection with Toxoplasma gondii, infection with Toxoplasma gondii increases the risk of type-1 diabetes, or both processes occur.


  • rema: Rare Event Meta Analysis

    by Brinley N. Zabriskie, Benjamin Kinard, Chris Sypherd, Ryan Whetten

  • A permutation‐based approach for heterogeneous meta‐analyses of rare events

    by Brinley N. Zabriskie, Chris Corcoran, Pralay Senchaudhuri

    The increasingly widespread use of meta‐analysis has led to growing interest in meta‐analytic methods for rare events and sparse data. Conventional approaches tend to perform very poorly in such settings. Recent work in this area has provided options for sparse data, but these are still often hampered when heterogeneity across the available studies differs based on treatment group. We propose a permutation‐based approach based on conditional logistic regression that accommodates this common contingency, providing more reliable statistical tests when such patterns of heterogeneity are observed. We find that commonly used methods can yield highly inflated Type I error rates, low confidence interval coverage, and bias when events are rare and non‐negligible heterogeneity is present. Our method often produces much lower Type I error rates and higher confidence interval coverage than traditional methods in these circumstances. We illustrate the utility of our method by comparing it to several other methods via a simulation study and analyzing an example data set, which assess the use of antibiotics to prevent acute rheumatic fever.


  • A comparison of confidence distribution approaches for rare event meta‐analysis

    by Brinley N. Zabriskie, Chris Corcoran, Pralay Senchaudhuri

    Meta‐analysis of rare event data has recently received increasing attention due to the challenging issues rare events pose to traditional meta‐analytic methods. One specific way to combine information and analyze rare event meta‐analysis data utilizes confidence distributions (CDs). While several CD methods exist, no comparisons have been made to determine which method is best suited for homogeneous or heterogeneous meta‐analyses with rare events. In this article, we review several CD methods: Fisher's classicP‐value combination method, one that combinesP‐value functions, another that combines confidence intervals, and one that combines confidence log‐likelihood functions. We compare these CD approaches, and we propose and compare variations of these methods to determine which method produces reliable results for homogeneous or heterogeneous rare event meta‐analyses. We find that for homogeneous rare event data, most CD methods perform very well. On the other hand, for heterogeneous rare event data, there is a clear split in performance between some CD methods, with some performing very poorly and others performing reasonably well.


  • When Your Permutation Test is Doomed to Fail

    by William F. Christensen, Brinley N. Zabriskie

    A two-tailed test comparing the means of two independent populations is perhaps the most commonly used hypothesis test in quantitative research, featured centrally in medical research, A/B testing, and throughout the sciences. When data are skewed, the standard two-tailed t test is not appropriate and the permutation test comparing the two means (or medians) has been a widely recommended alternative, with statistical authors and statistical software packages touting the permutation test’s utility, particularly for small samples. In this presentation, we illustrate that when the two samples are skewed and the sample sizes are unequal, the two-tailed permutation test (as traditionally implemented) can in some cases have power equal to zero, even when the k highest values in the combined data are all found in the group with k observations. Further, in many cases the standard permutation test exhibits decreasing power as the total sample size increases! We illustrate the causes of these perverse properties via both simulation and real-world examples, and we recommend approaches for ameliorating or avoiding these potential problems.